Thinking outside the gate: single-cell assessments in multiple dimensions

Affiliations

• ¹ Netherlands Cancer Institute, 1006 BE Amsterdam, the Netherlands.
• ² Institute for Cell Biology, Department of Immunology, University of Tübingen, 72076 Tuebingen, Germany.
• ³ Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada.
• ⁴ University of Southampton, Southampton SO17 1BJ, UK.
• ⁵ ImmunoTechnology Section, Vaccine Research Center, NIH, Bethesda, MD 20892, USA.
• ⁶ Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC 27710, USA.
• ⁷ Helmholtz Zentrum München, 85764 Neuherberg, Germany.
• ⁸ Vaccine and Infectious Disease Division, Department of Biostatistics, Bioinformatics, and Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA 98155, USA.
• ⁹ Center for Cancer Immune Therapy, Herlev Hospital, 2730 Herlev, Denmark.
• ¹⁰ Institute for Immunity, Transplantation, and Infection, Stanford School of Medicine, Stanford University, Stanford, CA 94305, USA.
• ¹¹ Immatics Biotechnologies GmbH, 72076 Tübingen, Germany.
• ¹² David D. Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
• ¹³ Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA 30322, USA.
• ¹⁴ J. Craig Venter Institute, La Jolla, CA 92037, USA; Department of Pathology, University of California, San Diego, San Diego, CA 92093, USA.
• ¹⁵ Department of Clinical Oncology, Leiden University Medical Center, 2300 RA Leiden, the Netherlands.
• ¹⁶ Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
• ¹⁷ Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada. Electronic address: rbrinkman@bccrc.ca.
• ¹⁸ BioNTech RNA Pharmaceuticals GmbH, 55131 Mainz, Germany. Electronic address: cebritten@web.de.